PLUS THERAPEUTICS Inc. (PSTV) Financial Statements (2024 and earlier)

Company Profile

Business Address 4200 MARATHON BLVD.
AUSTIN, TX 78756
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18,12018,4008,34617,5525,2619,550
Cash and cash equivalents18,12018,4008,34617,5525,2619,550
Restricted cash and investments    4040675
Receivables    1,169286145
Inventory, net of allowances, customer advances and progress billings    1072,9473,183
Inventory    1072,9473,183
Other current assets3,6971,3248299571,1141,311
Total current assets:21,81719,7249,17519,8259,64814,864
Noncurrent Assets
Operating lease, right-of-use asset248341636781
Property, plant and equipment1,3241,4771,8202,1792,5593,052
Intangible assets, net (including goodwill)4664234583729,87911,129
Goodwill3723723723723,9223,922
Intangible assets, net (excluding goodwill)945186 5,9577,207
Other noncurrent assets121616721,9052,570
Total noncurrent assets:2,0502,2572,9303,40414,34316,751
TOTAL ASSETS:23,86721,98112,10523,22923,99131,615
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:10,1344,1512,0813,2793,3574,790
Employee-related liabilities781738679746874
Accounts payable8,3642,6117893277201,297
Accrued liabilities1,1361892761,1231,1911,599
Other undisclosed accounts payable and accrued liabilities6345702781,1507001,020
Debt1,6081,6086,33511,20714,20213,624
Other undisclosed current liabilities110111123   
Total current liabilities:11,8525,8708,53914,48617,55918,414
Noncurrent Liabilities
Long-term debt and lease obligation 3,7865,274528654  
Long-term debt, excluding current maturities 3,7865,005    
Finance lease, liability    8
Liabilities, other than long-term debt1,784  8291107
Deferred revenue and credits107
Deferred revenue1,643   
Contract with customer, liability167
Deferred rent credit     124
Other liabilities    8  
Operating lease, liability141269528646
Other undisclosed noncurrent liabilities  (268)(521)6,92191694
Total noncurrent liabilities:5,5705,2755357,5831,207201
Total liabilities:17,42211,1459,07422,06918,76618,615
Equity
Equity, attributable to parent6,44510,8363,0311,1605,22513,000
Common stock3416741558
Treasury stock, value      
Additional paid in capital473,596457,730436,535426,426418,375413,304
Accumulated other comprehensive income     1,2181,387
Accumulated deficit(467,185)(446,910)(433,511)(425,270)(414,383)(401,749)
Total equity:6,44510,8363,0311,1605,22513,000
TOTAL LIABILITIES AND EQUITY:23,86721,98112,10523,22923,99131,615

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues     3,6712,689
Cost of revenue
(Cost of Goods and Services Sold)
   (107) (1,148)(1,225)
Other undisclosed gross profit      (1,318)
Gross profit:   (107) 2,523146
Operating expenses(19,936)(12,492)(9,887)(10,655)(16,979)(24,551)
Other undisclosed operating income224 4106,9981,7583,722
Operating loss:(19,712)(12,492)(9,584)(3,657)(12,698)(20,683)
Nonoperating income (expense)(563)(907)1,34337464(2,003)
Investment income, nonoperating1471950554333
Other nonoperating income     18013
Interest and debt expense(711)(932)(1,107)(1,855)(1,922)(2,049)
Loss from continuing operations before income taxes:(20,986)(14,331)(9,348)(5,138)(14,556)(24,735)
Other undisclosed income from continuing operations   1,1071,855  
Loss from continuing operations:(20,986)(14,331)(8,241)(3,283)(14,556)(24,735)
Loss before gain (loss) on sale of properties:(14,331)(8,241)(10,887)(14,556)(24,735)
Loss from discontinued operations    (7,604)  
Net loss:(20,986)(14,331)(8,241)(10,887)(14,556)(24,735)
Other undisclosed net income attributable to parent711932  1,9222,049
Net loss attributable to parent:(20,275)(13,399)(8,241)(10,887)(12,634)(22,686)
Preferred stock dividends and other adjustments    (554)(2,487)(3,977)
Net loss available to common stockholders, diluted:(20,275)(13,399)(8,241)(11,441)(15,121)(26,663)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(20,986)(14,331)(8,241)(10,887)(14,556)(24,735)
Comprehensive loss:(20,986)(14,331)(8,241)(10,887)(14,556)(24,735)
Other undisclosed comprehensive income, net of tax, attributable to parent     1,7532,178
Comprehensive loss, net of tax, attributable to parent:(20,986)(14,331)(8,241)(10,887)(12,803)(22,557)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: